Search research articles
Contact Us
Filters
Showing results (41-50 of 69) with videos related to
Page
of 7
Sort By:
Oncotargets and Therapy
|
December 26, 2018
Afatinib versus gemcitabine/cisplatin for first-line treatment of Chinese patients with advanced non-small-cell lung cancer harboring <i>EGFR</i> mutations: subgroup analysis of the LUX-Lung 6 trial
Yi-Long Wu, Chong-Rui Xu, Cheng-Ping Hu, et al.
Genome Research
|
June 15, 2018
Linking transcriptional and genetic tumor heterogeneity through allele analysis of single-cell RNA-seq data
Jean Fan, Hae-Ock Lee, Soohyun Lee, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 8, 2017
Continued use of afatinib with the addition of cetuximab after progression on afatinib in patients with EGFR mutation-positive non-small-cell lung cancer and acquired resistance to gefitinib or erlotinib
Leora Horn, Scott Gettinger, D Ross Camidge, et al.
Scientific Reports
|
November 28, 2023
Single cell and spatial transcriptomics analysis of kidney double negative T lymphocytes in normal and ischemic mouse kidneys
Sepideh Gharaie, Kyungho Lee, Kathleen Noller, et al.
Cell
|
August 28, 2016
Cell-Type-Specific Alternative Splicing Governs Cell Fate in the Developing Cerebral Cortex
Xiaochang Zhang, Ming Hui Chen, Xuebing Wu, et al.
Biorxiv : the Preprint Server for Biology
|
May 18, 2026
Spatial imprints of emergent cardiomyocyte states in the pressure-overloaded heart
Yuening Liu, Annabelle M Coles, Jonah Castiglione, et al.
Nature Communications
|
May 11, 2026
The multi-kinase inhibitor tinengotinib as monotherapy or combined with atezolizumab in advanced solid tumors: a phase Ib/II trial
Panpan Zhang, Zuoxing Niu, Hongqian Guo, et al.
NPJ Precision Oncology
|
December 10, 2025
Targeting high-risk MYC-overexpressed osteosarcoma with an Aurora kinase inhibitor:--results from a pilot umbrella trial
Kai Tian, Yafei Jiang, Mengxiong Sun, et al.
The Lancet. Gastroenterology & Hepatology
|
December 5, 2025
Tinengotinib for adults with advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 trial
Milind Javle, Christos Fountzilas, Chih-Yi Liao, et al.
Biorxiv : the Preprint Server for Biology
|
June 3, 2024
Human BioMolecular Atlas Program (HuBMAP): 3D Human Reference Atlas Construction and Usage
Katy Börner, Philip D Blood, Jonathan C Silverstein, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 69) with videos related to
Sort By:
Page
of 7
Oncotargets and Therapy
|
December 26, 2018
Afatinib versus gemcitabine/cisplatin for first-line treatment of Chinese patients with advanced non-small-cell lung cancer harboring <i>EGFR</i> mutations: subgroup analysis of the LUX-Lung 6 trial
Yi-Long Wu, Chong-Rui Xu, Cheng-Ping Hu, et al.
Genome Research
|
June 15, 2018
Linking transcriptional and genetic tumor heterogeneity through allele analysis of single-cell RNA-seq data
Jean Fan, Hae-Ock Lee, Soohyun Lee, et al.
Lung Cancer (Amsterdam, Netherlands)
|
November 8, 2017
Continued use of afatinib with the addition of cetuximab after progression on afatinib in patients with EGFR mutation-positive non-small-cell lung cancer and acquired resistance to gefitinib or erlotinib
Leora Horn, Scott Gettinger, D Ross Camidge, et al.
Scientific Reports
|
November 28, 2023
Single cell and spatial transcriptomics analysis of kidney double negative T lymphocytes in normal and ischemic mouse kidneys
Sepideh Gharaie, Kyungho Lee, Kathleen Noller, et al.
Cell
|
August 28, 2016
Cell-Type-Specific Alternative Splicing Governs Cell Fate in the Developing Cerebral Cortex
Xiaochang Zhang, Ming Hui Chen, Xuebing Wu, et al.
Biorxiv : the Preprint Server for Biology
|
May 18, 2026
Spatial imprints of emergent cardiomyocyte states in the pressure-overloaded heart
Yuening Liu, Annabelle M Coles, Jonah Castiglione, et al.
Nature Communications
|
May 11, 2026
The multi-kinase inhibitor tinengotinib as monotherapy or combined with atezolizumab in advanced solid tumors: a phase Ib/II trial
Panpan Zhang, Zuoxing Niu, Hongqian Guo, et al.
NPJ Precision Oncology
|
December 10, 2025
Targeting high-risk MYC-overexpressed osteosarcoma with an Aurora kinase inhibitor:--results from a pilot umbrella trial
Kai Tian, Yafei Jiang, Mengxiong Sun, et al.
The Lancet. Gastroenterology & Hepatology
|
December 5, 2025
Tinengotinib for adults with advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 trial
Milind Javle, Christos Fountzilas, Chih-Yi Liao, et al.
Biorxiv : the Preprint Server for Biology
|
June 3, 2024
Human BioMolecular Atlas Program (HuBMAP): 3D Human Reference Atlas Construction and Usage
Katy Börner, Philip D Blood, Jonathan C Silverstein, et al.
Page
of 7